vs
Side-by-side financial comparison of CRYO CELL INTERNATIONAL INC (CCEL) and SES AI Corp (SES). Click either name above to swap in a different company.
CRYO CELL INTERNATIONAL INC is the larger business by last-quarter revenue ($7.8M vs $4.6M, roughly 1.7× SES AI Corp). CRYO CELL INTERNATIONAL INC runs the higher net margin — -48.7% vs -373.5%, a 324.8% gap on every dollar of revenue. CRYO CELL INTERNATIONAL INC produced more free cash flow last quarter ($1.2M vs $-11.1M).
Cryo-Cell International, Inc. is a cord blood bank. It was founded by Dan Richard in 1989. Cryo-Cell International is the first private cord blood bank to separate and store stem cells. Cryo-Cell is headquartered outside of Tampa, in Oldsmar, Florida. In January 1997, the Company's stock began trading on the NASDAQ Small Cap market under symbol CCEL.
SES S.A. is a Luxembourgish communications satellite operator supplying video and data connectivity worldwide to broadcasters, content and internet service providers, mobile and fixed network operators, governments and institutions.
CCEL vs SES — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $7.8M | $4.6M |
| Net Profit | $-3.8M | $-17.0M |
| Gross Margin | 77.9% | 11.3% |
| Operating Margin | -50.6% | -387.7% |
| Net Margin | -48.7% | -373.5% |
| Revenue YoY | -2.3% | — |
| Net Profit YoY | -105.1% | 50.7% |
| EPS (diluted) | $-0.46 | $-0.05 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $7.8M | $4.6M | ||
| Q3 25 | $7.8M | $7.1M | ||
| Q2 25 | $7.9M | $3.5M | ||
| Q1 25 | $8.0M | $5.8M | ||
| Q4 24 | $8.0M | — | ||
| Q3 24 | $8.1M | — | ||
| Q2 24 | $8.0M | — | ||
| Q1 24 | $7.9M | — |
| Q4 25 | $-3.8M | $-17.0M | ||
| Q3 25 | $749.4K | $-20.9M | ||
| Q2 25 | $355.8K | $-22.7M | ||
| Q1 25 | $282.9K | $-12.4M | ||
| Q4 24 | $-1.9M | — | ||
| Q3 24 | $1.1M | — | ||
| Q2 24 | $655.8K | — | ||
| Q1 24 | $556.2K | — |
| Q4 25 | 77.9% | 11.3% | ||
| Q3 25 | 77.0% | 51.1% | ||
| Q2 25 | 76.6% | 73.7% | ||
| Q1 25 | 75.1% | 78.7% | ||
| Q4 24 | 78.4% | — | ||
| Q3 24 | 73.6% | — | ||
| Q2 24 | 74.8% | — | ||
| Q1 24 | 73.7% | — |
| Q4 25 | -50.6% | -387.7% | ||
| Q3 25 | 24.3% | -262.0% | ||
| Q2 25 | 18.8% | -652.3% | ||
| Q1 25 | 13.3% | -401.7% | ||
| Q4 24 | -1.5% | — | ||
| Q3 24 | 17.2% | — | ||
| Q2 24 | 17.3% | — | ||
| Q1 24 | 10.5% | — |
| Q4 25 | -48.7% | -373.5% | ||
| Q3 25 | 9.6% | -293.9% | ||
| Q2 25 | 4.5% | -642.2% | ||
| Q1 25 | 3.5% | -214.6% | ||
| Q4 24 | -23.2% | — | ||
| Q3 24 | 13.0% | — | ||
| Q2 24 | 8.2% | — | ||
| Q1 24 | 7.1% | — |
| Q4 25 | $-0.46 | $-0.05 | ||
| Q3 25 | $0.09 | $-0.06 | ||
| Q2 25 | $0.04 | $-0.07 | ||
| Q1 25 | $0.03 | $-0.04 | ||
| Q4 24 | $-0.23 | — | ||
| Q3 24 | $0.13 | — | ||
| Q2 24 | $0.08 | — | ||
| Q1 24 | $0.07 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $3.3M | $29.5M |
| Total DebtLower is stronger | $8.4M | — |
| Stockholders' EquityBook value | $-18.6M | $214.8M |
| Total Assets | $61.7M | $272.6M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $3.3M | $29.5M | ||
| Q3 25 | $3.2M | $35.3M | ||
| Q2 25 | $4.4M | $11.8M | ||
| Q1 25 | $3.5M | $56.1M | ||
| Q4 24 | $3.5M | — | ||
| Q3 24 | $2.1M | — | ||
| Q2 24 | $1.5M | — | ||
| Q1 24 | $979.6K | — |
| Q4 25 | $8.4M | — | ||
| Q3 25 | $8.4M | — | ||
| Q2 25 | $8.4M | — | ||
| Q1 25 | $8.5M | — | ||
| Q4 24 | $8.5M | — | ||
| Q3 24 | $8.5M | — | ||
| Q2 24 | $8.5M | — | ||
| Q1 24 | $8.6M | — |
| Q4 25 | $-18.6M | $214.8M | ||
| Q3 25 | $-14.8M | $228.2M | ||
| Q2 25 | $-15.6M | $249.2M | ||
| Q1 25 | $-14.7M | $269.9M | ||
| Q4 24 | $-13.2M | — | ||
| Q3 24 | $-9.6M | — | ||
| Q2 24 | $-10.7M | — | ||
| Q1 24 | $-10.3M | — |
| Q4 25 | $61.7M | $272.6M | ||
| Q3 25 | $63.2M | $288.8M | ||
| Q2 25 | $64.4M | $290.5M | ||
| Q1 25 | $64.4M | $306.0M | ||
| Q4 24 | $64.7M | — | ||
| Q3 24 | $62.9M | — | ||
| Q2 24 | $62.6M | — | ||
| Q1 24 | $61.7M | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $1.3M | $-10.4M |
| Free Cash FlowOCF − Capex | $1.2M | $-11.1M |
| FCF MarginFCF / Revenue | 15.5% | -243.7% |
| Capex IntensityCapex / Revenue | 0.9% | 15.6% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $5.2M | $-61.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.3M | $-10.4M | ||
| Q3 25 | $2.5M | $-14.3M | ||
| Q2 25 | $707.0K | $-10.8M | ||
| Q1 25 | $954.1K | $-22.8M | ||
| Q4 24 | $2.2M | — | ||
| Q3 24 | $2.4M | — | ||
| Q2 24 | $1.8M | — | ||
| Q1 24 | $-356.9K | — |
| Q4 25 | $1.2M | $-11.1M | ||
| Q3 25 | $2.5M | $-14.7M | ||
| Q2 25 | $644.6K | $-11.6M | ||
| Q1 25 | $892.0K | $-23.7M | ||
| Q4 24 | $2.1M | — | ||
| Q3 24 | $2.3M | — | ||
| Q2 24 | $21.5K | — | ||
| Q1 24 | $-814.6K | — |
| Q4 25 | 15.5% | -243.7% | ||
| Q3 25 | 31.9% | -206.9% | ||
| Q2 25 | 8.1% | -329.6% | ||
| Q1 25 | 11.2% | -410.0% | ||
| Q4 24 | 26.8% | — | ||
| Q3 24 | 27.9% | — | ||
| Q2 24 | 0.3% | — | ||
| Q1 24 | -10.4% | — |
| Q4 25 | 0.9% | 15.6% | ||
| Q3 25 | 0.5% | 6.0% | ||
| Q2 25 | 0.8% | 22.8% | ||
| Q1 25 | 0.8% | 15.8% | ||
| Q4 24 | 0.1% | — | ||
| Q3 24 | 2.3% | — | ||
| Q2 24 | 21.8% | — | ||
| Q1 24 | 5.8% | — |
| Q4 25 | — | — | ||
| Q3 25 | 3.38× | — | ||
| Q2 25 | 1.99× | — | ||
| Q1 25 | 3.37× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.32× | — | ||
| Q2 24 | 2.70× | — | ||
| Q1 24 | -0.64× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
